Details for New Drug Application (NDA): 019940
✉ Email this page to a colleague
The generic ingredient in ACTINEX is masoprocol. There is one drug master file entry for this compound. Additional details are available on the masoprocol profile page.
Summary for 019940
Tradename: | ACTINEX |
Applicant: | Univ Az Cancer Ctr |
Ingredient: | masoprocol |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019940
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | 10% | ||||
Approval Date: | Sep 4, 1992 | TE: | RLD: | No |
Expired US Patents for NDA 019940
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Univ Az Cancer Ctr | ACTINEX | masoprocol | CREAM;TOPICAL | 019940-001 | Sep 4, 1992 | ⤷ Subscribe | ⤷ Subscribe |
Univ Az Cancer Ctr | ACTINEX | masoprocol | CREAM;TOPICAL | 019940-001 | Sep 4, 1992 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription